A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926
Clinical trial NCT01730456 · COMPLETED
Trial details
- NCT number
- NCT01730456
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.